Trials / Completed
CompletedNCT02265913
Comparative Safety and Efficacy of Two Antiviral Treatments in the Treatment of Recurrent Herpes Simplex Labialis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 4,076 (actual)
- Sponsor
- Padagis LLC · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
To compare safety and efficacy of Perrigo's antiviral drug product compared to an FDA approved antiviral drug product in the treatment of cold sores.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Acyclovir 5 percent (Perrigo) | |
| DRUG | Acyclovir 5 percent (Reference) | |
| DRUG | Placebo cream |
Timeline
- Start date
- 2014-10-06
- Primary completion
- 2016-04-27
- Completion
- 2017-11-21
- First posted
- 2014-10-16
- Last updated
- 2021-10-22
- Results posted
- 2021-01-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02265913. Inclusion in this directory is not an endorsement.